Anzeige
Mehr »
Mittwoch, 19.08.2026 - Börsentäglich über 12.000 News
NurExone Biologic! Massiver Turnaround - jetzt die Rallye?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
125 Leser
Artikel bewerten:
(0)

Pace Analytical: New Jersey Legionella Law Creates Two Compliance Deadlines for Covered Buildings and Facilities

Covered buildings must develop a water management program by September 2026 and put it into practice just three months later.

PENNSAUKEN, NJ / ACCESS Newswire / August 19, 2026 / New Jersey building owners and facility managers subject to the state's new Legionella law are facing two key compliance milestones: a September 12, 2026, deadline to develop a water management program and a December 12, 2026, deadline to put that program into practice. The distinction is important for covered facilities that may be focused on completing written plans. Implementation, however, requires coordinated procedures, monitoring, corrective actions and documentation designed to help manage Legionella risk in building water systems.

The law applies to a range of facilities, including hospitals, nursing homes, assisted living communities, certain hotels and residential buildings, correctional facilities and buildings with aerosol-generating water devices such as cooling towers, pools, spas and indoor ornamental fountains. Specific requirements vary depending on the type of facility and water system involved.

Facilities that fail to comply may face civil penalties of up to $2,000 for a first violation and up to $5,000 for a second or subsequent violation. A violation that results in serious injury or death may carry a penalty of up to $10,000.

Legionella bacteria occur naturally in freshwater but can grow inside building water systems, including plumbing, hot-water tanks, cooling towers and decorative fountains. People can become sick when they inhale small water droplets containing bacteria. Legionnaires' disease is a severe form of pneumonia that can be fatal, particularly for older adults, people who smoke and those with weakened immune systems or underlying health conditions. The CDC reports that approximately one in 10 people who develop Legionnaires' disease die from complications related to the illness. Research also suggests that the actual number of cases may be higher than the number reported.

"Every Legionella sample represents a real building and real people who may be affected by the quality of water systems," said Dr. Abe Collum, Director of Water Safety & Management at Pace Building Sciences. "New Jersey's law is a reminder that compliance is only the starting point. The real goal is prevention. By using a practical water management program, reliable testing and clear documentation, we can help facilities identify risks and act before those risks become public health concerns."

Pace provides independent Legionella testing through laboratory locations that participate in the CDC's Environmental Legionella Isolation Techniques Evaluation (ELITE) proficiency testing program. ELITE evaluates whether laboratories can correctly isolate Legionella from water samples using culture-based methods. Participating laboratory locations must demonstrate that ability on a recurring basis.

Pace works alongside water-treatment professionals and facility teams, providing independent testing that can help them understand their water systems and evaluate the controls designed to manage Legionella risk.

With the first compliance deadline approaching in September 2026, covered facilities can understand where they stand by evaluating their readiness. Pace Building Sciences offers a free readiness assessment to identify gaps in water management programs, testing practices and documentation before implementation is required. Learn more here.

Pace is a portfolio partner of Leonard Green & Partners and Aurora Capital Partners.

###

About Pace

Pace makes the world a safer, healthier place. Pace people are committed to advancing the science of the pharmaceutical and biotechnology industries in our Life Sciences laboratories and supporting businesses, industries, consulting firms, government agencies, and more through our Analytical Services laboratories. Pace offers local-level service backed by a national laboratory network. For customers with in-house labs, Pace provides a range of professional services to keep their operations moving forward. Pace people work in partnership with customers by providing the service, science, and the data they need to make critical decisions that benefit us all. More at PACELABS.com

Media Contact:
Brooke Schwartzel, Brand & Communications Manager
Brooke.Schwartzel@pacelabs.com

Jennifer Hernández, Corporate Communications Specialist
Jennifer.hernandez@pacelabs.com

SOURCE: Pace Analytical



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/business-and-professional-services/new-jersey-legionella-law-creates-two-compliance-deadlines-for-c-1208793

© 2026 ACCESS Newswire
Achtung, Korrektur!
Die Börsen laufen heiß. Trotz geopolitischer Krisen und steigender Zinsen klettern viele Indizes weiter Richtung Allzeithoch. Doch unter der Oberfläche zeigen sich erste Risse: Der Abverkauf bei Halbleiter-, KI- und Space-Aktien macht deutlich, wie schnell sich die Stimmung drehen kann.

Besonders gefährlich ist die aktuelle Gemengelage aus schwacher Saisonalität, dünner Liquidität in den Sommermonaten und historisch hohen Bewertungen. Selbst vermeintlich sichere Blue Chips sind inzwischen teuer bewertet und damit anfällig für Korrekturen. Gleichzeitig liefern technische Indikatoren erste Warnsignale. So werden viele Rekordstände nicht mehr bestätigt.

Für Anleger steigen die Risiken spürbar. Wer jetzt nicht genauer hinschaut, läuft Gefahr, auf dem falschen Fuß erwischt zu werden.

In unserem aktuellen Spezialreport zeigen wir fünf Aktien, bei denen die Abwärtsrisiken besonders hoch sind – und wo sich Gewinnmitnahmen oder sogar Short-Strategien anbieten könnten.

Jetzt den kostenlosen Report sichern – bevor die Korrektur Fahrt aufnimmt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.